Tag: Cancer: Colon

No significant differences seen at gene or pathway level according to age; chemotherapy response, survival equivalent by age groups

Segments with incomplete resection have increased risk for any metachronous neoplasia, advanced neoplasia

Cross-validated sensitivity improved with multitarget FIT compared with standard FIT test for advanced neoplasia and advanced adenoma

Follow-up colonoscopy often classified as 'diagnostic' test, not 'routine screening,' and therefore not covered by insurance

Survival better compared with colon cancer patients in the general U.S. population, overall and in subgroups including Black versus White race

Findings seen in a large study of veterans undergoing diagnostic colonoscopy

Survival advantage greatest for diagnosis at age 35 through 39 years with stage I or II disease versus diagnosis at age 51 to 55 years

Risk for CRC-related mortality reduced with screening endoscopy for those older than 75 years who do not have significant comorbidities

Link between family history of polyps and CRC risk strengthened with increasing number of relatives and lower age at polyp diagnosis

USPSTF concludes with moderate certainty that CRC screening has moderate net benefit for those aged 45 to 49 years